These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 11592955)
1. Role of COX-2-derived metabolites in regulation of the renal hemodynamic response to norepinephrine. Llinás MT; López R; Rodríguez F; Roig F; Salazar FJ Am J Physiol Renal Physiol; 2001 Nov; 281(5):F975-82. PubMed ID: 11592955 [TBL] [Abstract][Full Text] [Related]
2. Renal changes induced by a cyclooxygenase-2 inhibitor during normal and low sodium intake. Rodríguez F; Llinás MT; González JD; Rivera J; Salazar FJ Hypertension; 2000 Aug; 36(2):276-81. PubMed ID: 10948090 [TBL] [Abstract][Full Text] [Related]
3. Role of cyclooxygenase-2-derived metabolites and nitric oxide in regulating renal function. Llinás MT; Rodríguez F; Moreno C; Salazar FJ Am J Physiol Regul Integr Comp Physiol; 2000 Nov; 279(5):R1641-6. PubMed ID: 11049846 [TBL] [Abstract][Full Text] [Related]
4. Role of cyclooxygenase-2 in the prolonged regulation of renal function. Roig F; Llinás MT; López R; Salazar FJ Hypertension; 2002 Nov; 40(5):721-8. PubMed ID: 12411468 [TBL] [Abstract][Full Text] [Related]
5. Role of nitric oxide and cyclooxygenase-2 in regulating the renal hemodynamic response to norepinephrine. López R; Llinas MT; Roig F; Salazar FJ Am J Physiol Regul Integr Comp Physiol; 2003 Feb; 284(2):R488-93. PubMed ID: 12388442 [TBL] [Abstract][Full Text] [Related]
6. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. Catella-Lawson F; McAdam B; Morrison BW; Kapoor S; Kujubu D; Antes L; Lasseter KC; Quan H; Gertz BJ; FitzGerald GA J Pharmacol Exp Ther; 1999 May; 289(2):735-41. PubMed ID: 10215647 [TBL] [Abstract][Full Text] [Related]
7. Role of prostaglandins in the renal response to calcium infusion. Lahera V; Fiksen-Olsen MJ; Romero JC Am J Physiol; 1990 Apr; 258(4 Pt 2):F1096-9. PubMed ID: 2330974 [TBL] [Abstract][Full Text] [Related]
8. Renal eicosanoids and renal hemodynamics in early borderline hypertension. Lebel M; Grose JH Clin Invest Med; 1991 Dec; 14(6):525-34. PubMed ID: 1794206 [TBL] [Abstract][Full Text] [Related]
9. Distinct role of intrarenal cyclooxygenase-1/2 in chronic unilateral renal ischemia. Tokuyama H; Hayashi K; Matsuda H; Kubota E; Honda M; Okubo K; Ozawa Y; Saruta T Nephron; 2002 Sep; 92(1):183-91. PubMed ID: 12187101 [TBL] [Abstract][Full Text] [Related]
10. Eicosanoid modulation of the norepinephrine effect on blood pressure and renal hemodynamics in humans. Isenring P; Lebel M; Falardeau P; Grose JH Prostaglandins Leukot Essent Fatty Acids; 1996 Jan; 54(1):59-63. PubMed ID: 8992495 [TBL] [Abstract][Full Text] [Related]
11. Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide. Nüsing RM; Reinalter SC; Peters M; Kömhoff M; Seyberth HW Clin Pharmacol Ther; 2001 Oct; 70(4):384-90. PubMed ID: 11673754 [TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Belton O; Byrne D; Kearney D; Leahy A; Fitzgerald DJ Circulation; 2000 Aug; 102(8):840-5. PubMed ID: 10952950 [TBL] [Abstract][Full Text] [Related]
13. Changes in renal vascular sensitivity and arterial pressure associated with sodium intake during long-term intrarenal norepinephrine infusion in dogs. Cowley AW; Lohmeier TE Hypertension; 1979; 1(6):549-58. PubMed ID: 396248 [TBL] [Abstract][Full Text] [Related]
14. Renal Effects of Cyclooxygenase Inhibition When Nitric Oxide Synthesis Is Reduced and Angiotensin II Levels Are Enhanced. López R; Llinás MT; Salazar E; Salazar FJ J Cardiovasc Pharmacol; 2015 May; 65(5):465-72. PubMed ID: 25945864 [TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG II-dependent malignant hypertension. Opay AL; Mouton CR; Mullins JJ; Mitchell KD Am J Physiol Renal Physiol; 2006 Sep; 291(3):F612-8. PubMed ID: 16622181 [TBL] [Abstract][Full Text] [Related]
16. Renal effects of prostaglandin inhibition during increases in renal venous pressure. Fiksen-Olsen MJ; Romero JC Am J Physiol; 1991 Apr; 260(4 Pt 2):F525-9. PubMed ID: 2012205 [TBL] [Abstract][Full Text] [Related]
17. Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study. Kramer HJ; Horacek V; Bäcker A; Vaneckova I; Heller J Kidney Blood Press Res; 2004; 27(1):10-7. PubMed ID: 14583658 [TBL] [Abstract][Full Text] [Related]
18. Nimesulide, a cyclooxygenase-2 preferential inhibitor, impairs renal function in the newborn rabbit. Prévot A; Mosig D; Martini S; Guignard JP Pediatr Res; 2004 Feb; 55(2):254-60. PubMed ID: 14605244 [TBL] [Abstract][Full Text] [Related]
19. Spinal prostaglandin formation and pain perception following thoracotomy: a role for cyclooxygenase-2. McCrory C; Fitzgerald D Chest; 2004 Apr; 125(4):1321-7. PubMed ID: 15078741 [TBL] [Abstract][Full Text] [Related]
20. Selective cyclooxygenase-2 inhibition by nimesulide in man. Cullen L; Kelly L; Connor SO; Fitzgerald DJ J Pharmacol Exp Ther; 1998 Nov; 287(2):578-82. PubMed ID: 9808683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]